Palliation with Oesophageal Metal Stent of Pseudoachalasia from Gastric Carcinoma at the Cardia: A Case Report by Campo, Salvatore Maria Antonio et al.
Hindawi Publishing Corporation
Diagnostic and Therapeutic Endoscopy
Volume 2009, Article ID 791627, 4 pages
doi:10.1155/2009/791627
Case Report
Palliation with Oesophageal Metal Stent of Pseudoachalasia from
Gastric Carcinoma at the Cardia: ACase Report
SalvatoreMaria Antonio Campo,1 Roberto Lorenzetti,1 Marina de Matthaeis,1
CesareHassan,1 Angelo Zullo,1 Paola Cerro,2 and SergioMorini1
1Gastroenterology Unit, Nuovo Regina Margherita Hospital, Via Morosini 30, 00153 Rome, Italy
2Radiology Unit, Nuovo Regina Margherita Hospital, Via Morosini 30, 00153 Rome, Italy
Correspondence should be addressed to Salvatore Maria Antonio Campo, salvatorecampo@yahoo.com
Received 12 March 2009; Revised 6 May 2009; Accepted 29 May 2009
Recommended by Spiros D. Ladas
We present an 82-year-old woman with a 3-month history of progressive dysphagia and a normal initial upper gastrointestinal
endoscopy. The diagnosis of pseudoachalasia was suspected by oesophageal manometric and barium swallow studies, and
conﬁrmedbybiopsiesrevealinganintestinaltypecarcinomaofthestomachatarepeatedendoscopy.Inviewofthehistoryofheart
disease, diabetes, and old age, this patient was treated by a partially covered Ultraﬂex self-expanding metal stent (Boston Scientiﬁc,
Natick, MA, USA) placed into the oesophageal body with no direct complications and obtaining the relief from dysphagia.
During the 11-month follow-up she was treated for an iron deﬁciency anaemia due to reﬂux oesophagitis with ulcerations in the
oesophageal body and died from myocardial infarction. According to the localization of the cancer, the old age, and the presence
of comorbidities, we should recommend the insertion of a partially covered self-expanding metal stent as a reasonable palliative
treatment in selected subjects with pseudoachalasia.
Copyright © 2009 Salvatore Maria Antonio Campo et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Introduction
Pseudoachalasia was ﬁrstly recognized by Ogilvie in 1947
due to the involvement of the distal oesophagus, with
submucosal inﬁltration of the lower oesophageal sphincter
(LES) and cardia by a carcinoma as the most usual cause
[1]. Several reports have considered pseudoachalasia as a
secondary form of achalasia showing that these patients,
in contrast to those with idiopathic achalasia, are more
likely to be older (>60 years), with short duration of
symptoms (<1 year), and presenting with substantial weight
loss [2–6]. It mimics idiopathic achalasia because of the
same manometric ﬁndings, that is, loss of peristalsis in
the oesophageal body and lack of relaxation of the LES
[7–11]. The most common pathogenetic mechanism is the
direct involvement of the oesophageal myenteric plexus by
neoplastic cells from a wide variety of malignant cancers
inﬁltrating the mucosa at the cardia, although a distant
neoplasm may be seldom the cause [12, 13]. Pseudoachalasia
may be diﬃcult to diagnose in the early phase because of
the low diagnostic yield of either barium and endoscopic
examinations, false-negative rate up to 25% for endoscopic
biopsies to diagnose cancer being reported [14].
2.CaseReport
An 82-year-old white woman was referred to our Unit with
a 3-month history of dysphagia initially for solids, then also
for liquids, and weight loss. She was diagnosed with diabetes
and heart failure with arrhythmia because of a mitral valve
insuﬃciency10yearsbefore.Anupperendoscopyperformed
elsewhere 3 months before showed a normal oesophagus and
gastrooesophageal junction. She was unsuccessfully treated
with a 1-month course of proton pump inhibitors (PPIs)
because of the suspicion of a nonerosive reﬂux disease. To
rule out the diagnosis of achalasia we initially performed
an oesophageal manometry, which showed loss of peristalsis
in the oesophageal body, but it failed to investigate the
LES function because the manometric catheter could not be2 Diagnostic and Therapeutic Endoscopy
Figure 1: Contrast study shows the well-positioned stent into the
oesophageal body.
passed across the cardia. Thereafter, a barium swallow study
found a dilated oesophagus containing some food residue
with an irregular tapered narrow cardia. At this point a new
upper endoscopy conﬁrmed a dilated oesophagus containing
food. Moreover, by pushing hard the scope through the
narrow cardia, a mild irregularity of the cardia mucosa was
evident. Biopsies revealed an intestinal cell type carcinoma.
To assess the extent of the cancer, a CT scan was performed,
disclosing only the thickening of the gastric wall conﬁned to
the cardia without evidence of metastasis.
3.Patient’sOutcome,CurrentTreatment
Neither surgical treatment nor radiotherapy or chemother-
apy were considered suitable in such a patient with a
long history of diabetes and heart disease, whereas the
insertion of self-expanding metal stent was optioned as a
low risk procedure to rapidly improve her quality of life.
We chose the Ultraﬂex self-expanding midsection covered
distally releasing oesophageal metal stent (Boston Scientiﬁc,
Natick, MA, USA) because it provided the most favourable
results as far as stent placement, migration, long-term relief
of dysphagia, and occurrence of fewer complications [15–
18].
The stent had a length of 7cm, with an 18mm diameter
ofthebody anditsﬂaredproximalend23mm,andconsisted
of a knitted nitinol wire tube with a polyurethane layer,
which covered the midsection of the stent, and it was distally
released under ﬂuoroscopic control (Figure 1). The proximal
ﬂare of 23mm was able to prevent the most common
complication, that is, occurrence of stent migration, while
the body diameter of 18mm seemed to ﬁt appropriately with
the dilated oesophagus of a patient with pseudoachalasia.
Endoscopic assessment showed the correct oesophageal
placed stent without apparent evidence of neoplasia (Figures
2(a) and 2(b)). In the short period, she was able to eat
withoutcomplainingdysphagiaandshereceivedomeprazole
therapy. On the long term she presented iron deﬁciency
anaemia, which was treated with iron supplementation and
(a)
(b)
Figure 2: Endoscopic study shows the well-placed stent in the
oesophagus without evidence of cancer at the cardia.
blood transfusions, and she was recommended to sleep in a
sitting position to avoid regurgitation. The patients’ quality
of life remains acceptable and quite stable during the follow
up. An upper endoscopy was done only 3 months later
showing that the cause of anemia was the ulcerations in the
oesophagealbodyeitherasacomplicationofstentplacement
or a reﬂux oesophagitis. The oesophageal stent was correctly
placed without migration or tumor overgrowth. She was
followed up by telephone interviews for other 9 months
when she died because of a myocardial infarction.
4. Discussion
Pseudoachalasia is a rare entity, which has only been
described in a small subgroup of patients (5%) with two
patterns of malignant tumor inﬁltrating the mucosa at
the cardia. The most common type consists of malignant
stricture of the cardia which acts as a physical barrier to
the passage of food. A less frequent type is strictly related
to the malignant submucosal inﬁltration with secondary
impairmentofoesophagealpostganglionicLESinnervations,
maintaining the manometric pattern of achalasia stable even
after treatment [19].
Pseudoachalasia may be diﬃcult to diagnose because
multiple diagnostic procedures may fail to indicate the
neoplastic origin [14]. In particular, the ﬁndings of normalDiagnostic and Therapeutic Endoscopy 3
Table 1: Clinical course of patients with expandable metal stents for achalasia or pseudoachalasia (from reference 25, modiﬁed).
Age Sex Diagnosis Dilation Botox Metal Stent Duration Follow-up/death
86 M acha x6 not done Wallstent I 2 days proximal stent migration
80 M acha x4 x2 Wallstent I 3 months stent stenosis
81 F acha x6 not done Wallstent I 6 months stent occlusion by food bolus
81 F acha x2 x2 Wallstent II 2 weeks proximal stent occlusion
31 F pseudoacha x3 x2 Gianturco Rosch slipped oesophageal cancer metastasis/death
81 F pseudoacha x3 x2 Wallstent II 2 weeks myocardial infarction/death
biopsy or negative CT scans results should not lead to
complete reassurance of a benign aetiology, that may be
achieved only after repeated studies or surgical exploration
[20,21].Oesophagealendoscopicultrasoundcanprovidethe
level of tumor invasion, and the possible spread to regional
lymph nodes, but it has low accuracy in diﬀerentiating
mucosal from submucosal lesions at the lower oesophagus or
gastrooesophageal junction [22]. Oesophageal manometry
is important for the correct diagnosis in conjunction with
carefully barium swallow study, accurate endoscopic exam-
ination and biopsy of any mucosa irregularity at the cardia
region [2, 20].
In the pseudoachalasia the removal of the obstruction
at the cardia by either surgery and/or chemotherapy and/or
radiation may often allow the return of normal peristalsis
into the oesophagus [23]. However, in a minority of patients
with pseudoachalasia, where histological examination of the
distal oesophagus has shown inﬁltration of the myenteric
plexus, the typical oesophageal motor disorder has been
found stable even after a radical treatment of the neoplasia
[12, 13]. In these cases the rapidly relief of the dysphagia and
an acceptable quality of life without other more invasive or
debilitating treatments may be considered as the main goal
in view of their short-life expectancy.
Recently, the use of expandable oesophageal metal stents
havebeenproposedasadditionaltherapeuticoptioninacha-
lasia and in a few cases of pseudoachalasia when the other
palliative options, that is, oesophageal dilation or surgery
or botox, failed. Moreover, temporary use of self-expanding
metal stents have been used for benign oesophageal steno-
sis and ﬁstula in patients who failed other conventional
treatments [24–27]. Despite the initial therapeutic success,
the overall results were found to be disappointing, frequent
complications, such as aorta-enteric ﬁstula, oesophageal
perforation, stent migration, and severe reﬂux oesophagitis
being reported [28, 29]. In detail, an acceptable success has
beenachievedonly in those patients witheithermalignantor
benignstrictureofcardia,includingachalasia,bypositioning
a permanent or temporary expandable oesophageal metal
stent. Unfortunately, neither details on stent characteristics
nor full clinical information have been provided in these
cases [27, 28].
As far as the use of oesophageal metal stents in pseu-
doachalasia is concerned, data are scanty and basically
disappointing (Table 1)[ 25]. Based on peculiar clinical
characteristics of our patient, we attempted to place an
oesophageal self-expanding partially covered metal stent,
either pneumatic dilation or botox injection at the LES
having a high probability of failure. Moreover, pneumatic
dilation is associated with a deﬁnite risk of perforation. We
achieved a therapeutic success with a good quality of life,
anemia due to erosive oesophagitis with regurgitation being
the only complications.
In conclusion, the insertion of a self-expanding metal
stent into the oesophageal body should be proposed in
particular types of pseudoachalasia caused by a cancer at
the cardia when a short-life expectancy is presumed or other
therapeutic approaches are impracticable.
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